Back
KLBF - Kalbe Farma

KLBF – No significant impact from Trump’s policy

14 August 2025

KLBF – No significant impact from Trump’s policy Kalbe Farma (KLBF) has not experienced any significant impact from global trade tensions caused by Trump’s tariff policy on certain export products. Currently, KLBF has no sales exposure to the US, focusing instead on markets in ASEAN, Africa, and Asia. Note that, KLBF posted revenue of IDR17.07 tn (+4.5% yoy) and net profit of IDR2.02 tn (+10.77% yoy) in 1H25. For this year, KLBF targets revenue and net profit growth of around 6–8% yoy. (Source : Kontan)

Related Research

Consumer
KLBF - Perbaikan ekonomi topang performa bisnis di masa depan
Winny Rahardja 08 April 2022 See Detail
Healthcare
KLBF - 9M25 results came in-line on solid 3Q25 sales growth
Andre Suntono 31 October 2025 See Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 August 2022 See Detail